Anna Brackenridge

1.8k total citations
27 papers, 432 citations indexed

About

Anna Brackenridge is a scholar working on Endocrinology, Diabetes and Metabolism, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Anna Brackenridge has authored 27 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Obstetrics and Gynecology and 8 papers in Surgery. Recurrent topics in Anna Brackenridge's work include Gestational Diabetes Research and Management (11 papers), Diabetes Management and Research (10 papers) and Pancreatic function and diabetes (7 papers). Anna Brackenridge is often cited by papers focused on Gestational Diabetes Research and Management (11 papers), Diabetes Management and Research (10 papers) and Pancreatic function and diabetes (7 papers). Anna Brackenridge collaborates with scholars based in United Kingdom, Australia and Canada. Anna Brackenridge's co-authors include Siobhan Pender, John C. Pickup, Stephanie A. Amiel, Geraldine Gallen, Louisa Green, Pratik Choudhary, Fariba Shojaee‐Moradie, David Russell‐Jones, A. Margot Umpleby and Ewan R. Pearson and has published in prestigious journals such as PLoS ONE, Diabetes Care and Diabetes.

In The Last Decade

Anna Brackenridge

24 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Brackenridge United Kingdom 10 305 207 198 49 39 27 432
Goran Petrovski Qatar 15 458 1.5× 278 1.3× 262 1.3× 44 0.9× 43 1.1× 53 590
Elena Faleschini Italy 12 223 0.7× 111 0.5× 169 0.9× 20 0.4× 67 1.7× 38 405
A. Riis Denmark 9 458 1.5× 274 1.3× 133 0.7× 21 0.4× 101 2.6× 10 804
Sara Charleer Belgium 10 655 2.1× 399 1.9× 418 2.1× 9 0.2× 15 0.4× 21 693
M. Bogoev Denmark 6 405 1.3× 194 0.9× 130 0.7× 67 1.4× 49 1.3× 10 463
Natasha Leibel United States 6 89 0.3× 96 0.5× 71 0.4× 13 0.3× 46 1.2× 12 300
Ulrike Schierloh Luxembourg 9 786 2.6× 564 2.7× 536 2.7× 6 0.1× 29 0.7× 18 873
Arndís F. Ólafsdóttir Sweden 11 940 3.1× 527 2.5× 553 2.8× 11 0.2× 34 0.9× 17 1.0k
Nicolin Datz Germany 11 364 1.2× 253 1.2× 263 1.3× 3 0.1× 39 1.0× 27 490
Sirkku Tulokas Finland 4 76 0.2× 91 0.4× 52 0.3× 153 3.1× 54 1.4× 5 319

Countries citing papers authored by Anna Brackenridge

Since Specialization
Citations

This map shows the geographic impact of Anna Brackenridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Brackenridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Brackenridge more than expected).

Fields of papers citing papers by Anna Brackenridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Brackenridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Brackenridge. The network helps show where Anna Brackenridge may publish in the future.

Co-authorship network of co-authors of Anna Brackenridge

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Brackenridge. A scholar is included among the top collaborators of Anna Brackenridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Brackenridge. Anna Brackenridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parsons, Judith, Kia‐Chong Chua, Anna Brackenridge, et al.. (2025). Medication prescribing and pregnancy-related risk factors for women with type 2 diabetes of reproductive age within primary care: a cross-sectional investigation for the PREPARED study. BMJ Open Diabetes Research & Care. 13(2). e004312–e004312. 2 indexed citations
2.
Pender, Siobhan, Thomas Johnston, YF Liu, et al.. (2025). Ethnicity and socioeconomic status do not influence glycaemic outcomes of a tubeless hybrid closed‐loop system (Omnipod® 5) in adults with type 1 diabetes. Diabetes Obesity and Metabolism. 27(9). 5052–5063.
3.
Brackenridge, Anna, et al.. (2024). Impact of the use of a smartphone‐based blood glucose management system within a maternal diabetes service. Practical Diabetes. 41(3). 16–23.
4.
Forbes, Angus, Janet Anderson, Debra Bick, et al.. (2023). Interventions to enhance pre‐pregnancy care for women with type 2 diabetes: A systematic review of the literature. Diabetic Medicine. 40(8). e15105–e15105. 6 indexed citations
8.
Parsons, Judith, Rita Forde, Anna Brackenridge, et al.. (2022). The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial. PLoS ONE. 17(12). e0273992–e0273992. 5 indexed citations
9.
Simpson, Anna, et al.. (2022). Symptoms of Anxiety and Depression Are Independently Associated With Impaired Awareness of Hypoglycemia in Type 1 Diabetes. Diabetes Care. 45(10). 2456–2460. 12 indexed citations
11.
Forde, Rita, et al.. (2019). A qualitative study exploring the factors that influence the uptake of pre‐pregnancy care among women with Type 2 diabetes. Diabetic Medicine. 37(6). 1038–1048. 21 indexed citations
12.
Marshall, Dominic C., et al.. (2019). Do-It-Yourself Artificial Pancreas Systems in Type 1 Diabetes: Perspectives of Two Adult Users, a Caregiver and Three Physicians. Diabetes Therapy. 10(5). 1553–1564. 32 indexed citations
13.
Maltese, Giuseppe, et al.. (2018). Peripheral neuropathy in diabetes: it's not always what it looks like. Diabetic Medicine. 35(10). 1457–1459. 2 indexed citations
14.
Pickup, John C., et al.. (2013). Nonmetabolic Complications of Continuous Subcutaneous Insulin Infusion: A Patient Survey. Diabetes Technology & Therapeutics. 16(3). 145–149. 89 indexed citations
15.
Brackenridge, Anna, N. Jackson, Michael Stolinski, et al.. (2009). Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids. Diabetic Medicine. 26(5). 532–539. 12 indexed citations
16.
Liu, YF, et al.. (2009). Cerebral cavernoma: an emerging long‐term consequence of external beam radiation in childhood. Clinical Endocrinology. 73(5). 555–560. 9 indexed citations
17.
Brackenridge, Anna. (2006). Emergency management of diabetes and hypoglycaemia. Emergency Medicine Journal. 23(3). 183–185. 43 indexed citations
18.
Brackenridge, Anna, Ewan R. Pearson, Fariba Shojaee‐Moradie, et al.. (2006). Contrasting Insulin Sensitivity of Endogenous Glucose Production Rate in Subjects With Hepatocyte Nuclear Factor-1β and -1α Mutations. Diabetes. 55(2). 405–411. 42 indexed citations
19.
Brackenridge, Anna, et al.. (2005). Multicentric reticulohistiocytosis and pregnancy. BJOG An International Journal of Obstetrics & Gynaecology. 112(5). 672–673. 10 indexed citations
20.
Brackenridge, Anna, Leigh Breen, & David Russell‐Jones. (2003). Growth hormone deficiency and pregnancy. Endocrine Abstracts. 5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026